NCPA's qAM

qAM

NCPA serves up facts on onerous DIR fees

by NCPA | Sep 11, 2019

Pharmacy DIR fees and the damage they cause were on the menu at a congressional briefing on Wednesday. NCPA Director of Congressional Affairs Adam Harbison told the approximately 40 attendees that pharmacy DIR fees have increased 45,000 percent in less than 10 years, raising drug prices and putting many pharmacies out of business. Harbison explained how DIR fees hurt consumers and pharmacies. The briefing was sponsored by the Food Marketing Institute, in coordination with NCPA, in order for congressional staffers to hear directly from both supermarket and community pharmacy businesses who are feeling the firsthand effects of DIR fees. Attendees also heard from congressional staff who are championing the bipartisan Phair Pricing Act of 2019 (H.R. 1034/S.640) to learn how the legislation would benefit both consumer wallets and pharmacies. They also got a pill bottle of mints with this fun and absolutely truthful label. (NCPA thanks FMI for their support in the DIR fight!)